Espinoza Octavio bought LGND
December 16, 2025 · Form 4 insider transaction
Espinoza Octavio bought 69 shares of Ligand Pharmaceuticals Incorporated at $57.22 per share, a transaction worth $3.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
69
Price
$57.22
Total value
$3.9K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after27,449
OwnershipDirect
10b5-1 planNo
AmendedNo